A. Farris

2.5k total citations
81 papers, 1.6k citations indexed

About

A. Farris is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, A. Farris has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 18 papers in Cancer Research. Recurrent topics in A. Farris's work include Cancer Treatment and Pharmacology (38 papers), Colorectal Cancer Treatments and Studies (21 papers) and Breast Cancer Treatment Studies (16 papers). A. Farris is often cited by papers focused on Cancer Treatment and Pharmacology (38 papers), Colorectal Cancer Treatments and Studies (21 papers) and Breast Cancer Treatment Studies (16 papers). A. Farris collaborates with scholars based in Italy, United Kingdom and United States. A. Farris's co-authors include Luigi Maiorino, Giorgio Mustacchi, A. De Matteis, B. Massidda, Alfonso M. Pluchinotta, A. Scanni, Francesco Boccardo, Vito Lorusso, A. Rubagotti and Luigi Dogliotti and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Agricultural and Food Chemistry.

In The Last Decade

A. Farris

80 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Farris Italy	23	949	599	408	353	287	81	1.6k
Massimo Lopez Italy	21	1.6k 1.7×	516 0.9×	598 1.5×	207 0.6×	405 1.4×	59	2.2k
Luigi Di Lauro Italy	25	886 0.9×	328 0.5×	307 0.8×	238 0.7×	398 1.4×	113	1.7k
G. Deplanque France	23	1.3k 1.4×	542 0.9×	812 2.0×	91 0.3×	633 2.2×	77	2.3k
Ioannis A. Voutsadakis Canada	27	1.2k 1.3×	639 1.1×	474 1.2×	182 0.5×	914 3.2×	161	2.3k
J. Bonneterre France	9	764 0.8×	464 0.8×	462 1.1×	513 1.5×	224 0.8×	28	1.3k
Stephen Welch Canada	24	1.0k 1.1×	279 0.5×	388 1.0×	182 0.5×	626 2.2×	124	1.9k
T. Tominaga Japan	18	825 0.9×	720 1.2×	236 0.6×	459 1.3×	730 2.5×	82	1.7k
Aneeta Patel United States	25	548 0.6×	278 0.5×	127 0.3×	207 0.6×	716 2.5×	56	1.7k
Jessica Read United Kingdom	9	733 0.8×	165 0.3×	514 1.3×	181 0.5×	428 1.5×	11	1.6k
Chung-Tsen Hsueh United States	19	556 0.6×	200 0.3×	305 0.7×	82 0.2×	416 1.4×	55	1.2k

Countries citing papers authored by A. Farris

Since Specialization

Citations

This map shows the geographic impact of A. Farris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Farris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Farris more than expected).

Fields of papers citing papers by A. Farris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Farris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Farris. The network helps show where A. Farris may publish in the future.

Co-authorship network of co-authors of A. Farris

This figure shows the co-authorship network connecting the top 25 collaborators of A. Farris. A scholar is included among the top collaborators of A. Farris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Farris. A. Farris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farina, Gabriella, Flavia Longo, Olga Martelli, et al.. (2011). Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Receptor Mutations. Clinical Lung Cancer. 12(2). 138–141. 13 indexed citations

Mustacchi, Giorgio, Mauro Mansutti, Chiara Sacco, et al.. (2009). Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study. Annals of Oncology. 20(4). 655–659. 15 indexed citations

Palomba, Grazia, Angela Loi, Giovanna Piras, et al.. (2009). A role of BRCA1 and BRCA2germline mutations in breast cancer susceptibility within Sardinian population. BMC Cancer. 9(1). 245–245. 17 indexed citations

Palomba, Grazia, Marina Pisano, Antonio Cossu, et al.. (2005). Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital‐based screening. Cancer. 104(6). 1172–1179. 24 indexed citations

Berruti, Alfredo, Raffaella Bitossi, G. Gorzegno, et al.. (2005). Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. British Journal of Cancer. 92(4). 634–638. 8 indexed citations

Comella, Pasquale, D. Natale, A. Farris, et al.. (2005). Capecitabine plus oxaliplatin for the first‐line treatment of elderly patients with metastatic colorectal carcinoma. Cancer. 104(2). 282–289. 69 indexed citations

Palmeri, S., Stefano Spada, Gianfranco Filippelli, et al.. (2005). Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study. Oncology. 68(4-6). 438–445. 16 indexed citations

Berruti, Alfredo, Raffaella Bitossi, Alberto Bottini, et al.. (2004). Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naïve metastatic breast cancer patients. European Journal of Cancer. 41(2). 249–255. 7 indexed citations

Comella, P., A. Farris, Vito Lorusso, et al.. (2003). Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma. British Journal of Cancer. 89(6). 992–996. 17 indexed citations

10.

Comella, P., E. Crucitta, Ferdinando De Vita, et al.. (2002). Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group. Annals of Oncology. 13(6). 866–873. 23 indexed citations

11.

Tampellini, Marco, Alfredo Berruti, G. Gorzegno, et al.. (2001). Independent Factors Predict Supranormal CA 15-3 Serum Levels in Advanced Breast Cancer Patients at First Disease Relapse. Tumor Biology. 22(6). 367–373. 14 indexed citations

12.

Gridelli, Cesare, L. Frontini, Federica Perrone, et al.. (2000). Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. British Journal of Cancer. 83(6). 707–714. 51 indexed citations

13.

Dogliotti, Luigi, Silvio Danese, Alfredo Berruti, et al.. (1998). Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. Cancer Chemotherapy and Pharmacology. 41(4). 333–338. 23 indexed citations

14.

Gebbia, Vittorio, A. Farris, Biagio Agostara, et al.. (1997). Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck. Cancer. 79(7). 1394–1400. 16 indexed citations

15.

Dogliotti, Luigi, Alfredo Berruti, Paolo Zola, et al.. (1996). Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial.. Journal of Clinical Oncology. 14(4). 1165–1172. 44 indexed citations

16.

Boccardo, Francesco, D. Amoroso, A. Rubagotti, et al.. (1993). Endocrine Therapy of Breast Cancer. Annals of the New York Academy of Sciences. 698(1). 318–328. 7 indexed citations

17.

Martoni, Andrea, et al.. (1990). Comparative Phase II Study of Idarubicin versus Doxorubicin in Advanced Breast Cancer. Oncology. 47(5). 427–432. 24 indexed citations

18.

Martoni, Andrea, et al.. (1989). A Randomized Clinical Trial with a Weekly Regimen of 5-Fluorouracil with or without Folinic Acid in Advanced Gastrointestinal Adenocarcinomas: A Preliminary Report. Journal of Chemotherapy. 1(3). 197–202. 1 indexed citations

19.

Filippi, G, P.M. Mannucci, Rosa Coppola, et al.. (1984). Studies on hemophilia A in Sardinia bearing on the problems of multiple allelism, carrier detection, and differential mutation rate in the two sexes.. PubMed. 36(1). 44–71. 14 indexed citations

20.

Fatichenti, F., A. Farris, & Pietrino Deiana. (1983). Aging effect of flor formation by Saccharomyces bailii var. bailii on a Spanish-type sherry. Journal of Fermentation Technology. 61(6). 637–641. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact